May 13 (Reuters) - Aap Implantate AG AAQG.DE :
* Q1 EBITDA, COMPANY RECORDED A SUBSTANTIAL YEAR-ON-YEAR
IMPROVEMENT IN Q1 OF 2019 (+37%) TO EUR -1.0 MILLION
* Q1 SALES UP ON CORRESPONDING PERIOD IN PREVIOUS YEAR BY
26% TO
EUR 3.5 MILLION (Q1/2018: EUR 2.8 MILLION)
* FOR Q2 OF 2019 AAP ANTICIPATES SALES OF EUR 2.5 MILLION TO
EUR
3.5 MILLION
* FOR Q2 OF 2019 AAP ANTICIPATES SALES OF EUR 2.5 MILLION TO
EUR
3.5 MILLION FOR Q2 OF 2019 ANTICIPATES EBITDA (BEFORE ONE-TIME
EFFECTS) OF EUR -1.6 MILLION TO EUR -1.0 MILLION
Source text for Eikon: ID:nEQ25D6gra
Further company coverage: AAQG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))